Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Montefiore Medical Center
USWM, LLC (dba US WorldMeds)
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Mayo Clinic
Dragonfly Therapeutics
Ensem Therapeutics
Centre Oscar Lambret
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
University of California, Irvine
Eli Lilly and Company
ViroMissile, Inc.
Duke University
Tizona Therapeutics, Inc
Dana-Farber Cancer Institute
IDEAYA Biosciences
University of Colorado, Denver
Institut Curie
University of Oklahoma
Theravectys S.A.
Karolinska University Hospital
Daiichi Sankyo
SN BioScience
Perspective Therapeutics
Second Life Therapeutics
Varian, a Siemens Healthineers Company
Novartis
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
RenJi Hospital
BicycleTx Limited
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Institut Claudius Regaud
Bolt Biotherapeutics, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Exelixis
Bicara Therapeutics
Sensei Biotherapeutics, Inc.